文献速递妇科生殖医学

子宫内膜异位症与共病疾病的跨疾病分析揭示共享基因与分子通路并提出候选生物标志物

Cross-disorder analysis of endometriosis and its comorbid diseases reveals shared genes and molecular pathways and proposes putative biomarkers of endometriosis.
PubMed 文献 · Reprod Biomed Online · 2019-11-20

本研究通过系统综述识别子宫内膜异位症相关共病,利用Phenopedia数据库基因表达谱进行系统生物学分析,发现127个候选基因在子宫内膜异位症及其最密切共病中反复表达,定义为「子宫内膜异位症姊妹疾病」基因。富集分析显示这些基因主要参与免疫与药物反应、激素代谢和细胞增殖。在独立样本队列(n=207)中验证了16个基因(AGTR1、BDNF、C3、CCL2、CD40、CYP17A1、ESR1、IGF1、IGF2、IL10、MMP1、MMP7、MMP9、PGR、SERPINE1和TIMP2)与子宫内膜异位症的关联。

要点

  • 127个候选基因在子宫内膜异位症及其最密切共病中反复表达,称为子宫内膜异位症姊妹疾病基因。
  • 这些基因主要富集于免疫与药物反应、激素代谢和细胞增殖通路。
  • 在207个独立样本中验证了16个基因与子宫内膜异位症的关联。

核心结论

  • 研究揭示了子宫内膜异位症及其共病发病机制的分子过程,并识别了候选生物标志物。

研究设计与样本

  • 系统综述识别子宫内膜异位症相关共病,将疾病列表编码为MeSH术语,从Phenopedia数据库下载基因表达谱并进行系统生物学分析。
  • 在独立样本队列(n=207样本)中验证ESD基因表达。

主要发现

  • 识别出127个在子宫内膜异位症及其最密切共病中反复表达的候选基因,定义为子宫内膜异位症姊妹疾病(ESD)基因。
  • 富集分析显示这些候选基因主要参与免疫与药物反应、激素代谢和细胞增殖。
  • 在独立样本队列中验证了16个基因(AGTR1、BDNF、C3、CCL2、CD40、CYP17A1、ESR1、IGF1、IGF2、IL10、MMP1、MMP7、MMP9、PGR、SERPINE1和TIMP2)与子宫内膜异位症的关联。
  • 其中多个基因存在与子宫内膜异位症或其共病相关的多态性。

关键数值与推荐

  • 候选基因127个,验证样本量n=207,验证基因16个。

临床怎么用

  • 这些候选基因和通路可能有助于子宫内膜异位症的早期识别和靶向治疗开发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Women with endometriosis are considered to be at higher risk of several chronic diseases, such as autoimmune disorders, gynaecological cancers, asthma/atopic diseases and cardiovascular and inflammatory bowel diseases. Could the study of endometriosis-associated comorbidities help to identify potential biomarkers and target pathways of endometriosis? DESIGN: A systematic review was performed to identify all possible endometriosis-associated comorbid conditions. Next, this list of disorders was coded into MeSH terms, and the gene expression profiles were downloaded from the Phenopedia database and subsequently analysed following a systems biology approach. RESULTS: The results identified a group of 127 candidate genes that were recurrently expressed in endometriosis and its closest comorbidities and that were defined as 'endometriosis sibling disorders' (ESD). The enrichment analysis showed that these candidate genes are principally involved in immune and drug responses, hormone metabolism and cell proliferation, which are well-known hallmarks of endometriosis. The expression of ESD genes was then validated on independent sample cohorts (n = 207 samples), in which the involvement of 16 genes (AGTR1, BDNF, C3, CCL2, CD40, CYP17A1, ESR1, IGF1, IGF2, IL10, MMP1, MMP7, MMP9, PGR, SERPINE1 and TIMP2) in endometriosis was confirmed. Several of these genes harbour polymorphisms that associate to either endometriosis or its comorbid conditions. CONCLUSIONS: The study results highlight the molecular processes underlying the aetiopathogenesis of endometriosis and its comorbid conditions, and identify putative endometriosis biomarkers.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Vargas E, Aghajanova L, Gemzell-Danielsson K, et al. Cross-disorder analysis of endometriosis and its comorbid diseases reveals shared genes and molecular pathways and proposes putative biomarkers of endometriosis. Reprod Biomed Online. 2019. PMID: 31926826. doi:10.1016/j.rbmo.2019.11.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。